Relationship of Scoliosis with Pain and Respiratory Dysfunction in Patients with Duchenne Muscular DystrophyFunding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
10 June 2019
28 October 2019
04 December 2019 (online)
Introduction Scoliosis is one of the major causes of respiratory dysfunction in patients with Duchene muscular dystrophy (DMD). Also, progressive spinal deformity severely affects walking and sitting, and can also lead to pain and difficulty in patient care. Although the relationship between scoliosis and respiratory functions was extensively studied, its impact on pain has not been examined. Hereby, we aimed to evaluate the relationship between scoliosis and respiratory dysfunction and pain, together with the frequency of scoliosis in Turkish DMD patients.
Patients and Methods The demographical data, rate, and region of scoliosis, pain, and respiratory functions were evaluated in 69 male DMD patients. The severity of pain was evaluated with a visual analog scale (VAS) and the degree of scoliosis was assessed with Cobb angle. Forced vital capacity was used to grade the pulmonary functions.
Results Scoliosis was present in 52.2% of the patients, mainly in the dorsolumbar region. Pain was present in 53.6% of the patients, most commonly in the back and lumbar regions. The rate of pulmonary dysfunction was 49.3%. Of the 36 patients with scoliosis, prevalences of pain and respiratory dysfunction were 77.7 and 50.0%, respectively. Scoliosis was significantly associated with pain and respiratory dysfunction, as expected.
Conclusion The prevalence of pain and respiratory dysfunction is considerably high in DMD patients with scoliosis. These patients should be closely monitored for pain and deterioration in respiratory functions, to ease their daily care, increase their quality of life, and preserve the functionality, as long as possible.
- 1 Kurz LT, Mubarak SJ, Schultz P, Park SM, Leach J. Correlation of scoliosis and pulmonary function in Duchenne muscular dystrophy. J Pediatr Orthop 1983; 3 (03) 347-353
- 2 Mayer OH, Leinonen M, Rummey C, Meier T, Buyse GM, Group DS. ; DELOS Study Group. Efficacy of idebenone to preserve respiratory function above clinically meaningful thresholds for forced vital capacity (FVC) in patients with Duchenne muscular dystrophy. J Neuromuscul Dis 2017; 4 (03) 189-198
- 3 Suk KS, Lee BH, Lee HM. , et al. Functional outcomes in Duchenne muscular dystrophy scoliosis: comparison of the differences between surgical and nonsurgical treatment. J Bone Joint Surg Am 2014; 96 (05) 409-415
- 4 Birnkrant DJ, Bushby K, Bann CM. , et al; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 2018; 17 (03) 251-267
- 5 Malfair D, Flemming AK, Dvorak MF. , et al. Radiographic evaluation of scoliosis: review. AJR Am J Roentgenol 2010; 194 (3, Suppl): S8-S22
- 6 Polat M, Sakinci O, Ersoy B, Sezer RG, Yilmaz H. Assessment of sleep-related breathing disorders in patients with Duchenne muscular dystrophy. J Clin Med Res 2012; 4 (05) 332-337
- 7 von Baeyer CL, Lin V, Seidman LC, Tsao JC, Zeltzer LK. Pain charts (body maps or manikins) in assessment of the location of pediatric pain. Pain Manag 2011; 1 (01) 61-68
- 8 Mukaka MM. Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med J 2012; 24 (03) 69-71
- 9 Alman BA, Raza SN, Biggar WD. Steroid treatment and the development of scoliosis in males with Duchenne muscular dystrophy. J Bone Joint Surg Am 2004; 86 (03) 519-524
- 10 Manzur AY, Kuntzer T, Pike M, Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev 2008; (01) CD003725
- 11 Balaban B, Matthews DJ, Clayton GH, Carry T. Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect. Am J Phys Med Rehabil 2005; 84 (11) 843-850
- 12 Duport G, Gayet E, Pries P. , et al. Spinal deformities and wheelchair seating in Duchenne muscular dystrophy: twenty years of research and clinical experience. Semin Neurol 1995; 15 (01) 29-37
- 13 Rodillo EB, Fernandez-Bermejo E, Heckmatt JZ, Dubowitz V. Prevention of rapidly progressive scoliosis in Duchenne muscular dystrophy by prolongation of walking with orthoses. J Child Neurol 1988; 3 (04) 269-274
- 14 Oda T, Shimizu N, Yonenobu K, Ono K, Nabeshima T, Kyoh S. Longitudinal study of spinal deformity in Duchenne muscular dystrophy. J Pediatr Orthop 1993; 13 (04) 478-488
- 15 Mullender M, Blom N, De Kleuver M. , et al. A Dutch guideline for the treatment of scoliosis in neuromuscular disorders. Scoliosis 2008; 3: 14
- 16 Engel JM, Kartin D, Carter GT, Jensen MP, Jaffe KM. Pain in youths with neuromuscular disease. Am J Hosp Palliat Care 2009; 26 (05) 405-412
- 17 Lager C, Kroksmark AK. Pain in adolescents with spinal muscular atrophy and Duchenne and Becker muscular dystrophy. Eur J Paediatr Neurol 2015; 19 (05) 537-546
- 18 Pangalila RF, van den Bos GA, Bartels B, Bergen M, Stam HJ, Roebroeck ME. Prevalence of fatigue, pain, and affective disorders in adults with Duchenne muscular dystrophy and their associations with quality of life. Arch Phys Med Rehabil 2015; 96 (07) 1242-1247
- 19 Zebracki K, Drotar D. Pain and activity limitations in children with Duchenne or Becker muscular dystrophy. Dev Med Child Neurol 2008; 50 (07) 546-552
- 20 Hunt A, Carter B, Abbott J, Parker A, Spinty S, deGoede C. Pain experience, expression and coping in boys and young men with Duchenne muscular dystrophy—a pilot study using mixed methods. Eur J Paediatr Neurol 2016; 20 (04) 630-638